Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 95

1.

Primary sclerosing cholangitis is associated with abnormalities in CFTR.

Werlin S, Scotet V, Uguen K, Audrezet MP, Cohen M, Yaakov Y, Safadi R, Ilan Y, Konikoff F, Galun E, Mizrahi M, Slae M, Sayag S, Cohen-Cymberknoh M, Wilschanski M, Ferec C.

J Cyst Fibros. 2018 May 26. pii: S1569-1993(18)30115-2. doi: 10.1016/j.jcf.2018.04.005. [Epub ahead of print]

PMID:
29807875
2.

Identification and Characterization of Novel Receptor-Interacting Serine/Threonine-Protein Kinase 2 Inhibitors Using Structural Similarity Analysis.

Salla M, Aguayo-Ortiz R, Danmaliki GI, Zare A, Said A, Moore J, Pandya V, Manaloor R, Fong S, Blankstein AR, Gibson SB, Garcia LR, Meier P, Bhullar KS, Hubbard BP, Fiteh Y, Vliagoftis H, Goping IS, Brocks D, Hwang P, Velázquez-Martínez CA, Baksh S.

J Pharmacol Exp Ther. 2018 May;365(2):354-367. doi: 10.1124/jpet.117.247163. Epub 2018 Mar 19.

PMID:
29555876
3.

Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.

Strazzabosco M, Fiorotto R, Cadamuro M, Spirli C, Mariotti V, Kaffe E, Scirpo R, Fabris L.

Biochim Biophys Acta. 2018 Apr;1864(4 Pt B):1374-1379. doi: 10.1016/j.bbadis.2017.07.023. Epub 2017 Jul 25. Review.

PMID:
28754453
4.

The intestinal microbiome and paediatric liver disease.

Leung DH, Yimlamai D.

Lancet Gastroenterol Hepatol. 2017 Jun;2(6):446-455. doi: 10.1016/S2468-1253(16)30241-2. Review.

PMID:
28497760
5.

Genetic Discoveries Highlight Environmental Factors as Key Drivers of Liver Disease.

Chung BK, Karlsen TH.

Dig Dis. 2017;35(4):323-333. doi: 10.1159/000456583. Epub 2017 May 3. Review.

PMID:
28468012
6.

"Biliary Diseases with Pancreatic Counterparts": Cross-sectional Imaging Findings.

Katabathina VS, Flaherty EM, Dasyam AK, Menias CO, Riddle ND, Lath N, Kozaka K, Matsui O, Nakanuma Y, Prasad SR.

Radiographics. 2016 Mar-Apr;36(2):374-92. doi: 10.1148/rg.2016150071. Epub 2016 Feb 1. Review.

PMID:
26824512
7.

Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease.

Bramuzzo M, Martelossi S, Torre G, Cardile S, Arrigo S, Vignola S, Ferrari F, Zuin G, Illiceto MT, Gasparetto M, Pellegrino S, Romano C, Maggiore G, Montico M, Aloi M; SIGENP IBD Group.

J Pediatr Gastroenterol Nutr. 2016 Aug;63(2):259-64. doi: 10.1097/MPG.0000000000001078.

PMID:
26756875
8.

Risk of Colorectal Cancer After Solid Organ Transplantation in the United States.

Safaeian M, Robbins HA, Berndt SI, Lynch CF, Fraumeni JF Jr, Engels EA.

Am J Transplant. 2016 Mar;16(3):960-7. doi: 10.1111/ajt.13549. Epub 2016 Jan 5.

9.

Can biliary endoscopy play a role in liver disease associated to cystic fibrosis?

Cantù P, Claut L, Elvevi A, Parzanese I, Maggioni M, Conte D, Penagini R, Colombo C.

J Cyst Fibros. 2015 Sep;14(5):E21-3. doi: 10.1016/j.jcf.2015.06.006. Epub 2015 Jul 26. No abstract available.

10.

The Cholangiopathies.

Lazaridis KN, LaRusso NF.

Mayo Clin Proc. 2015 Jun;90(6):791-800. doi: 10.1016/j.mayocp.2015.03.017. Epub 2015 May 6. Review.

11.

Cystic Fibrosis below the Diaphragm: Abdominal Findings in Adult Patients.

Lavelle LP, McEvoy SH, Ni Mhurchu E, Gibney RG, McMahon CJ, Heffernan EJ, Malone DE.

Radiographics. 2015 May-Jun;35(3):680-95. doi: 10.1148/rg.2015140110. Epub 2015 Apr 24. Review.

PMID:
25910185
12.

Surviving Sengstaken.

Jayakumar S, Odulaja A, Patel S, Davenport M, Ade-Ajayi N.

J Pediatr Surg. 2015 Jul;50(7):1142-6. doi: 10.1016/j.jpedsurg.2014.12.014. Epub 2014 Dec 24.

PMID:
25783327
13.

Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver.

Dhiman RK, Saraswat VA, Valla DC, Chawla Y, Behera A, Varma V, Agarwal S, Duseja A, Puri P, Kalra N, Rameshbabu CS, Bhatia V, Sharma M, Kumar M, Gupta S, Taneja S, Kaman L, Zargar SA, Nundy S, Singh SP, Acharya SK, Dilawari JB.

J Clin Exp Hepatol. 2014 Feb;4(Suppl 1):S2-S14. doi: 10.1016/j.jceh.2014.02.003. Epub 2014 Feb 25. Review.

14.

Liver disease in the adolescent.

Mavis AM, Alonso EM.

Clin Liver Dis. 2015 Feb;19(1):171-85. doi: 10.1016/j.cld.2014.09.010. Epub 2014 Nov 21. Review.

PMID:
25454303
15.

The liver in pediatric gastrointestinal disease.

Vo HD, Xu J, Rabinowitz SS, Fisher SE, Schwarz SM.

J Pediatr Gastroenterol Nutr. 2014 Sep;59(3):288-99. doi: 10.1097/MPG.0000000000000444. Review.

PMID:
25144777
16.

Cystic fibrosis related liver disease--another black box in hepatology.

Staufer K, Halilbasic E, Trauner M, Kazemi-Shirazi L.

Int J Mol Sci. 2014 Aug 4;15(8):13529-49. doi: 10.3390/ijms150813529. Review.

17.

Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.

Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD.

Gastroenterology. 2013 Sep;145(3):521-36. doi: 10.1053/j.gastro.2013.06.052. Epub 2013 Jul 1. Review.

18.

Genetic determinants of cholestasis.

Hirschfield GM.

Clin Liver Dis. 2013 May;17(2):147-59. doi: 10.1016/j.cld.2012.12.002. Review.

PMID:
23540495
19.

Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States.

Maisonneuve P, Marshall BC, Knapp EA, Lowenfels AB.

J Natl Cancer Inst. 2013 Jan 16;105(2):122-9. doi: 10.1093/jnci/djs481. Epub 2012 Nov 24.

PMID:
23178438
20.

Liver biopsy in modern clinical practice: a pediatric point-of-view.

Ovchinsky N, Moreira RK, Lefkowitch JH, Lavine JE.

Adv Anat Pathol. 2012 Jul;19(4):250-62. doi: 10.1097/PAP.0b013e31825c6a20. Review.

Supplemental Content

Loading ...
Support Center